The Readout Loud

Podcast autorstwa STAT - Czwartki

Czwartki

Kategorie:

346 Odcinki

  1. 283: A CRISPR milestone, algorithms amok, & biotech mixology

    Opublikowany: 16.11.2023
  2. From Tradeoffs: Can the U.S. put an end to surprise ambulance bills?

    Opublikowany: 13.11.2023
  3. 282: Lilly’s obesity drug, the power of radiation, & a biotech implosion

    Opublikowany: 9.11.2023
  4. 281: Decoding biotech hype, the Sarepta saga, & au revoir to a CEO

    Opublikowany: 2.11.2023
  5. 280: ESMO highlights, Roivant's big deal, & biotech VC on the rise

    Opublikowany: 26.10.2023
  6. 279: Live from the 2023 STAT Summit

    Opublikowany: 19.10.2023
  7. 278: Merger Mondays, Ozempic panic, & CRISPR'd pigs

    Opublikowany: 12.10.2023
  8. 277: Is the Nobel committee evolving? Plus, preventing public health's wiliest virus

    Opublikowany: 5.10.2023
  9. 276: Who discovered GLP-1? Plus: BrainStorm at the FDA and biotech's slump

    Opublikowany: 28.09.2023
  10. 275: A thorny ALS debate at the FDA, and the promise of artificial wombs

    Opublikowany: 21.09.2023
  11. 274: Covid’s latest surge, Alnylam at the FDA, & the end of an era

    Opublikowany: 14.09.2023
  12. 273: Back to school for biotech, Biogen's potential pivot, & Illumina's next chapter

    Opublikowany: 7.09.2023
  13. 272: Vivek's star turn, leaky drug data, & biotech as family business

    Opublikowany: 24.08.2023
  14. 271: Racing for gene therapy, a pioneering approval, & startups in the lurch

    Opublikowany: 18.08.2023
  15. 270: Your guide to Wegovy’s blockbuster heart study

    Opublikowany: 10.08.2023
  16. 269: Biotech layoffs, eye drug drama, & gene therapy milestones

    Opublikowany: 3.08.2023
  17. 268: Biogen's sticky situation, Wegovy's risks, & biotech insider trading

    Opublikowany: 27.07.2023
  18. 267: BridgeBio's big week, Lilly's Alzheimer's data, & succession at Stanford

    Opublikowany: 20.07.2023
  19. 266: Wegovy in the brain, pivotal Alzheimer's data, & pulling Threads

    Opublikowany: 13.07.2023
  20. 265: Novavax's CEO promises a turnaround & how Lilly roiled the obesity market

    Opublikowany: 29.06.2023

4 / 18

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Visit the podcast's native language site